Is NADPH Oxidase a Potential Target for Cancer Therapy?
Given its role in cancer progression, NADPH oxidase is considered a promising target for cancer therapy. Inhibitors of NADPH oxidase have been shown to reduce ROS levels and suppress tumor growth in preclinical models. These inhibitors could potentially be used in combination with other treatments to enhance their efficacy. However, the challenge lies in specifically targeting the cancer-promoting activities of NADPH oxidase without affecting its normal physiological functions.
